IBDEI0SU ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,13265,2)
 ;;=^5005285
 ;;^UTILITY(U,$J,358.3,13266,0)
 ;;=H25.13^^80^756^4
 ;;^UTILITY(U,$J,358.3,13266,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13266,1,3,0)
 ;;=3^Cataract,Age-Related Nuclear,Bilateral
 ;;^UTILITY(U,$J,358.3,13266,1,4,0)
 ;;=4^H25.13
 ;;^UTILITY(U,$J,358.3,13266,2)
 ;;=^5005286
 ;;^UTILITY(U,$J,358.3,13267,0)
 ;;=H54.0^^80^757^1
 ;;^UTILITY(U,$J,358.3,13267,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13267,1,3,0)
 ;;=3^Blindness,Both Eyes
 ;;^UTILITY(U,$J,358.3,13267,1,4,0)
 ;;=4^H54.0
 ;;^UTILITY(U,$J,358.3,13267,2)
 ;;=^5006357
 ;;^UTILITY(U,$J,358.3,13268,0)
 ;;=H54.12^^80^757^2
 ;;^UTILITY(U,$J,358.3,13268,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13268,1,3,0)
 ;;=3^Blindness-Left Eye/Low Vision-Right Eye
 ;;^UTILITY(U,$J,358.3,13268,1,4,0)
 ;;=4^H54.12
 ;;^UTILITY(U,$J,358.3,13268,2)
 ;;=^5006360
 ;;^UTILITY(U,$J,358.3,13269,0)
 ;;=H54.11^^80^757^4
 ;;^UTILITY(U,$J,358.3,13269,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13269,1,3,0)
 ;;=3^Blindness-Right Eye/Low Vision-Left Eye
 ;;^UTILITY(U,$J,358.3,13269,1,4,0)
 ;;=4^H54.11
 ;;^UTILITY(U,$J,358.3,13269,2)
 ;;=^5006359
 ;;^UTILITY(U,$J,358.3,13270,0)
 ;;=H54.2^^80^757^7
 ;;^UTILITY(U,$J,358.3,13270,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13270,1,3,0)
 ;;=3^Low Vision,Both Eyes
 ;;^UTILITY(U,$J,358.3,13270,1,4,0)
 ;;=4^H54.2
 ;;^UTILITY(U,$J,358.3,13270,2)
 ;;=^5006361
 ;;^UTILITY(U,$J,358.3,13271,0)
 ;;=H54.3^^80^757^8
 ;;^UTILITY(U,$J,358.3,13271,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13271,1,3,0)
 ;;=3^Unqualified Visual Loss,Both Eyes
 ;;^UTILITY(U,$J,358.3,13271,1,4,0)
 ;;=4^H54.3
 ;;^UTILITY(U,$J,358.3,13271,2)
 ;;=^268886
 ;;^UTILITY(U,$J,358.3,13272,0)
 ;;=H54.41^^80^757^5
 ;;^UTILITY(U,$J,358.3,13272,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13272,1,3,0)
 ;;=3^Blindness-Right Eye/Normal Vision-Left Eye
 ;;^UTILITY(U,$J,358.3,13272,1,4,0)
 ;;=4^H54.41
 ;;^UTILITY(U,$J,358.3,13272,2)
 ;;=^5006363
 ;;^UTILITY(U,$J,358.3,13273,0)
 ;;=H54.42^^80^757^3
 ;;^UTILITY(U,$J,358.3,13273,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13273,1,3,0)
 ;;=3^Blindness-Left Eye/Normal Vision-Right Eye
 ;;^UTILITY(U,$J,358.3,13273,1,4,0)
 ;;=4^H54.42
 ;;^UTILITY(U,$J,358.3,13273,2)
 ;;=^5133518
 ;;^UTILITY(U,$J,358.3,13274,0)
 ;;=H54.7^^80^757^9
 ;;^UTILITY(U,$J,358.3,13274,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13274,1,3,0)
 ;;=3^Visual Loss,Unspec
 ;;^UTILITY(U,$J,358.3,13274,1,4,0)
 ;;=4^H54.7
 ;;^UTILITY(U,$J,358.3,13274,2)
 ;;=^5006368
 ;;^UTILITY(U,$J,358.3,13275,0)
 ;;=H54.8^^80^757^6
 ;;^UTILITY(U,$J,358.3,13275,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13275,1,3,0)
 ;;=3^Legal Blindness,as Defined in USA
 ;;^UTILITY(U,$J,358.3,13275,1,4,0)
 ;;=4^H54.8
 ;;^UTILITY(U,$J,358.3,13275,2)
 ;;=^5006369
 ;;^UTILITY(U,$J,358.3,13276,0)
 ;;=E11.9^^80^758^26
 ;;^UTILITY(U,$J,358.3,13276,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13276,1,3,0)
 ;;=3^DM Type 2 w/o Complications
 ;;^UTILITY(U,$J,358.3,13276,1,4,0)
 ;;=4^E11.9
 ;;^UTILITY(U,$J,358.3,13276,2)
 ;;=^5002666
 ;;^UTILITY(U,$J,358.3,13277,0)
 ;;=E11.39^^80^758^15
 ;;^UTILITY(U,$J,358.3,13277,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13277,1,3,0)
 ;;=3^DM Type 2 w/ Diabetic Ophthalmic Complications
 ;;^UTILITY(U,$J,358.3,13277,1,4,0)
 ;;=4^E11.39
 ;;^UTILITY(U,$J,358.3,13277,2)
 ;;=^5002643
 ;;^UTILITY(U,$J,358.3,13278,0)
 ;;=E11.36^^80^758^14
 ;;^UTILITY(U,$J,358.3,13278,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13278,1,3,0)
 ;;=3^DM Type 2 w/ Diabetic Cataract
 ;;^UTILITY(U,$J,358.3,13278,1,4,0)
 ;;=4^E11.36
 ;;^UTILITY(U,$J,358.3,13278,2)
 ;;=^5002642
